Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent
Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent
The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
Inclusion Criteria:
Patients enrolled in Protocol 127-014 who
Washington D.C., District of Columbia 20010, United States
Shawnee Mission, Kansas 66204, United States
Houston, Texas 77030, United States